Abstract-We examined the hypothesis that contraction of the carotid arteries to serotonin is normally inhibited by endothelial NO synthase (eNOS) and is enhanced in mice lacking the gene for eNOS. Because the influence of eNOS may vary with the sex of the mouse, we also tested whether responses to serotonin were dependent on sex. We studied carotid arteries in vitro from littermate control (eNOS ϩ/ϩ ) mice, heterozygous (eNOS ϩ/Ϫ ) mice, and homozygous eNOS-deficient (eNOS Ϫ/Ϫ ) mice (male and female). Contraction to serotonin was greater in male eNOS ϩ/ϩ mice than in female eNOS ϩ/ϩ mice. In male mice, contraction to serotonin increased by Ϸ40% and 2.5-fold in male eNOS ϩ/Ϫ and eNOS Ϫ/Ϫ mice, respectively. Contraction to serotonin was more than doubled in female eNOS ϩ/Ϫ mice and increased Ͼ5-fold in arteries from eNOS Ϫ/Ϫ mice. In contrast, maximum vasoconstriction to U46619 was similar in male and female eNOS ϩ/ϩ , eNOS ϩ/Ϫ , and eNOS Ϫ/Ϫ mice. Relaxation to acetylcholine was not different in male and female eNOS ϩ/ϩ or eNOS ϩ/Ϫ mice but was absent in eNOS Ϫ/Ϫ mice. These findings suggest that the contraction of carotid arteries to serotonin is influenced by the sex of the animal. eNOS deficiency in gene-targeted mice is associated with enhanced contraction to serotonin, particularly in female mice, providing direct evidence that eNOS is a major determinant of vascular effects of serotonin. The results with eNOS ϩ/Ϫ mice suggest a "gene-dosing" effect for vascular responses to serotonin. Key Words: NO synthase Ⅲ acetylcholine Ⅲ thromboxane Ⅲ mice Ⅲ genetically altered mice T he endothelium can modulate vascular function by the production and release of a variety of vasodilator and vasoconstrictor agents. 1 NO released from the endothelium has been identified as a major endothelium-derived relaxing factor 2 that primarily produces relaxation of vascular muscle by the activation of soluble guanylate cyclase and cGMPdependent protein kinase I. 3 In addition, studies that used pharmacological approaches and gene-targeted mice suggest that NO is the primary mediator of endothelium-dependent relaxation in several blood vessels, including coronary, carotid, and cerebral arteries. 4 -9 In addition to mediating vasorelaxation, a second major role for endothelium is to inhibit responses of vascular muscle to vasoconstrictors. For example, contraction of coronary and cerebral arteries to serotonin is augmented after the removal of endothelium. 10,11 Mechanisms that may account for increased vasoconstrictor responses to serotonin after endothelial removal may include deficiency of NO or other endothelium-derived relaxing factors that oppose the direct contractile effect of serotonin on vascular muscle. Inhibitors of NO synthase (NOS) increase vasoconstriction and/or decrease vasodilation to serotonin, 11-13 but limitations related to the specificity of these pharmacological agents may complicate the interpretation of the studies. This is particularly true if one is attempting to define the role of specific isoforms of ...